The newest drug, tenofovir alafenamide, has the edge in its safety profile for treating chronic hepatitis B infection.
MAUI, HAWAII – The biggest remaining challenge in the treatment of hepatitis C is to gain improved access to therapy, according to Steven L. Flamm...
From the Journals
Despite increasing prevalence of hepatitis C virus infection in pregnant women, infants exposed to the disease are screened at a very low rate.
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
Advances in drug therapy have made it possible to cure HCV infection. This article describes how best to screen, diagnose, and counsel these...
MAUI, HAWAII – Acute hepatitis C infection sometimes warrants treatment.
LAS VEGAS – Fibrates and other peroxisome proliferator-activated receptor agonists are emerging.